Precision Biosciences (DTIL) Revenue (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.31% |
| Dec 31, 2025 | 263,007.69% |
| Sep 30, 2025 | -27.78% |
| Jun 30, 2025 | -37.93% |
| Mar 31, 2025 | -95.45% |
| Dec 31, 2024 | 10.76% |
| Sep 30, 2024 | -98.85% |
| Jun 30, 2024 | 183.77% |
| Mar 31, 2024 | 149.84% |
| Dec 31, 2023 | -46.36% |
| Sep 30, 2023 | -33.70% |
| Jun 30, 2023 | 125.39% |
| Mar 31, 2023 | -17.15% |
| Dec 31, 2022 | 43.94% |
| Sep 30, 2022 | 92.75% |
| Jun 30, 2022 | 15.16% |
| Mar 31, 2022 | -47.67% |
| Dec 31, 2021 | -73.63% |
| Sep 30, 2021 | -65.07% |
| Jun 30, 2021 | 320.85% |
| Mar 31, 2021 | 84.82% |
| Dec 31, 2020 | 20.14% |
| Sep 30, 2020 | 583.02% |
| Jun 30, 2020 | -84.60% |
| Mar 31, 2020 | 7.30% |
| Dec 31, 2019 | 34.06% |
| Sep 30, 2019 | -9.72% |
| Jun 30, 2019 | -1.34% |
| Mar 31, 2019 | 10.57% |
| Dec 31, 2018 | 94.41% |
| Sep 30, 2018 | 35.59% |
| Jun 30, 2018 | 22.64% |